Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | Alpha Cancer Technologies - Alpha Cancer |
Description | Alpha Cancer Technologies About Us Our Products Alpha Fetoprotein (AFP) Immunomodulation Platform Targeted Immuno-Oncology Platform Pre-Clinical Studies A |
Keywords | N/A |
WebSite | alpha-cancer.com |
Host IP | 45.40.150.81 |
Location | United States |
Site | Rank |
US$1,091,324
Last updated: 2023-05-18 17:42:31
alpha-cancer.com has Semrush global rank of 9,698,597. alpha-cancer.com has an estimated worth of US$ 1,091,324, based on its estimated Ads revenue. alpha-cancer.com receives approximately 125,922 unique visitors each day. Its web server is located in United States, with IP address 45.40.150.81. According to SiteAdvisor, alpha-cancer.com is safe to visit. |
Purchase/Sale Value | US$1,091,324 |
Daily Ads Revenue | US$1,008 |
Monthly Ads Revenue | US$30,222 |
Yearly Ads Revenue | US$362,656 |
Daily Unique Visitors | 8,395 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
alpha-cancer.com. | A | 600 | IP: 45.40.150.81 |
alpha-cancer.com. | NS | 3600 | NS Record: ns56.domaincontrol.com. |
alpha-cancer.com. | NS | 3600 | NS Record: ns55.domaincontrol.com. |
alpha-cancer.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
alpha-cancer.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
alpha-cancer.com. | TXT | 3600 | TXT Record: MS=ms38177424 |
alpha-cancer.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:secureserver.net -all |
alpha-cancer.com. | TXT | 3600 | TXT Record: google-site-verification=2tfIBIOXViCsyc9fZu4YfJF2ry7zA5Uzy2K6cvpOSEE |
Alpha Cancer Technologies About Us Our Products Alpha Fetoprotein (AFP) Immunomodulation Platform Targeted Immuno-Oncology Platform Pre-Clinical Studies ACT-101 Pre-Clinical MG Studies ACT-101 Pre-Clinical IBD Studies ACT-901-3 Pre-Clinical IO Studies News Investors Menu About Us Our Products Alpha Fetoprotein (AFP) Immunomodulation Platform Targeted Immuno-Oncology Platform Pre-Clinical Studies ACT-101 Pre-Clinical MG Studies ACT-101 Pre-Clinical IBD Studies ACT-901-3 Pre-Clinical IO Studies News Investors Alpha Cancer Technologies Using Nature to Beat Cancer. Learn More About Us Our Products Alpha Fetoprotein (AFP) Immunomodulation Platform Targeted Immuno-Oncology Platform Pre-Clinical Studies ACT-101 Pre-Clinical MG Studies ACT-101 Pre-Clinical IBD Studies ACT-901-3 Pre-Clinical IO Studies News Investors Menu About Us Our Products Alpha Fetoprotein (AFP) Immunomodulation Platform Targeted Immuno-Oncology Platform Pre-Clinical Studies ACT-101 Pre-Clinical MG Studies ACT-101 |
HTTP/1.1 200 OK Accept-Ranges: bytes Age: 32217 Content-Length: 55777 Content-Type: text/html; charset=UTF-8 Date: Fri, 08 Jul 2022 23:51:20 GMT Vary: Accept-Encoding, User-Agent X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Cacheproxy-Retries: 0/2 X-Content-Type-Options: nosniff X-Fawn-Proc-Count: 1,0,24 X-Php-Version: 7.3 X-Xss-Protection: 1; mode=block |
Domain Name: ALPHA-CANCER.COM Registry Domain ID: 1522959515_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-10-07T14:40:22Z Creation Date: 2008-10-06T17:26:34Z Registry Expiry Date: 2022-10-06T17:26:34Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS55.DOMAINCONTROL.COM Name Server: NS56.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-07-09T08:50:00Z <<< |